This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_STOMACH_EXALLC for full statistics.
Malignant neoplasm of stomach
C3_STOMACH
stomach neoplasm: A benign or malignant neoplasm involving the stomach.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1960 |
4. Check minimum number of eventsNone |
1960 |
5. Include endpointsNone |
1960 |
6. Filter based on genotype QC (FinnGen only) |
1960 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of stomach
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
- Adenocarcinoma and papillary adenocarcinoma of stomach
- Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)
- Neuroendocrine tumor and carcinoma of stomach
- Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1960 | 641 | 1319 |
| Unadjusted period prevalence (%) | 0.46 | 0.22 | 0.58 |
| Median age at first event (years) | 68.00 | 65.63 | 69.16 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1822
- Matched controls
- 18218
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
107
Kela drug reimbursment
Pernicious anaemia
42.1
323.0
522
172
130
Kela drug reimbursment
Malignant tumour
16.3
323.0
893
1012
JDD00
NOMESCO Finland
Total gastrectomy and Roux-en-Y oesophagojejunostomy
3936.8
323.0
336
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
10.9
323.0
1318
3529
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
850.9
323.0
584
10
B03BA03
ATC
hydroxocobalamin; parenteral
14.2
323.0
665
707
8140/3-C16.9
ICD-O-3
Adenocarcinoma, NOS, of stomach, NOS
+∞
299.4
279
*
A03FA01
ATC
metoclopramide; systemic, rectal
7.3
296.6
918
2229
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
86.4
295.2
327
46
C16.00
ICD-10 Finland
Cardia
782.0
279.1
268
*
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
+∞
272.9
255
*
L01BC06
ATC
capecitabine; oral
18.7
259.6
417
285
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
82.8
257.2
287
41
8145/3-C16.9
ICD-O-3
Carcinoma, diffuse type of stomach, NOS
+∞
221.5
208
*
B81
ICPC
Anaemia vit B12/folate deficiency
13.1
211.1
395
378
C16.0
ICD-10 Finland
Malignant neoplasm: Cardia
+∞
208.4
196
*
C16.09
ICD-10 Finland
Malignant tumor of cardiac or other unspecified carcinoma
1114.4
207.4
199
*
A04AA02
ATC
granisetron; systemic, transdermal
11.0
206.9
424
487
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
62.8
198.4
231
42
H02AB02
ATC
dexamethasone; systemic
7.3
196.8
538
989
C16.2
ICD-10 Finland
Malignant neoplasm: Body of stomach
1972.4
179.1
171
*
C16.23
ICD-10 Finland
Malignant tumor of the corpus ventriculi diffuse carcinoma
+∞
168.4
159
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
11.8
167.7
327
331
C16.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of stomach
569.6
160.5
157
*
C16.20
ICD-10 Finland
Malignant tumor of the corpus ventriculi without histology
1696.5
158.7
152
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
34.5
140.3
184
59
C16.39
ICD-10 Finland
Malignant tumor of the antrum ventriculi other or unspecified carcinoma
360.5
135.6
135
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.5
134.9
318
444
C16.29
ICD-10 Finland
Malignant tumor of the corpus ventriculi other or unspecified carcinoma
348.8
131.3
131
*
JN4BD
NOMESCO Finland
Extensive body CT
4.9
126.2
477
1226
C16.30
ICD-10 Finland
Malignant tumor of the antrum ventriculi without histology
656.9
125.9
123
*
C16.3
ICD-10 Finland
Malignant neoplasm: Pyloric antrum
+∞
120.1
114
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
11.2
119.7
237
240
R4190
NOMESCO Finland
Nutritional therapy
14.1
117.7
208
165
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
110.8
114.6
124
12
C16.03
ICD-10 Finland
Malignant tumor of cardiac diffuse carcinoma
1134.6
110.7
107
*
C16.04
ICD-10 Finland
Malignant tumor of cardiac intestinal carcinoma
554.3
106.9
105
*
C16.33
ICD-10 Finland
Malignant tumor of the antrum ventriculi diffuse carcinoma
1056.0
103.3
100
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
16.5
103.1
170
113
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
46.5
102.7
126
29
C16.4
ICD-10 Finland
Malignant neoplasm: Pylorus
345.2
99.0
99
*
C16.24
ICD-10 Finland
Malignant tumor of the corpus ventriculi intestinal carcinoma
1011.3
99.0
96
*
Z51.5
ICD-10 Finland
Palliative care
5.4
97.3
321
691
N02AA05
ATC
oxycodone; systemic
3.6
96.1
539
1925
C16.34
ICD-10 Finland
Malignant tumor of the antrum ventriculi intestinal carcinoma
944.6
92.7
90
*
JDC20
NOMESCO Finland
Partial gastrectomy and Roux-en-Y reconstruction
122.4
86.8
93
8
A04AA01
ATC
ondansetron; systemic, rectal
5.7
84.6
264
527
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.6
83.0
263
534
JAH01
NOMESCO Finland
Laparoscopy
8.7
82.8
187
236
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
8.0
78.7
188
259
D74
ICPC
Malignant neoplasm stomach
780.0
76.9
75
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.9
75.5
168
206
A02BC02
ATC
pantoprazole; systemic
2.6
73.3
1293
8912
JN4AD
NOMESCO Finland
Body CT examination
4.4
72.0
285
730
8240/3-C16.9
ICD-O-3
Neuroendocrine tumor, NOS, of stomach, NOS
+∞
71.3
68
*
C16.01
ICD-10 Finland
Malignant tumor in cardia early diffuse gastric carcinoma early diffuse gastric carcinoma
+∞
70.3
67
*
8144/3-C16.9
ICD-O-3
Adenocarcinoma, intestinal type of stomach, NOS
+∞
70.3
67
*
JDC10
NOMESCO Finland
Partial gastrectomy and gastrojejunostomy
126.6
68.4
73
6
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.8
68.3
246
571
8144/3-C16.0
ICD-O-3
Adenocarcinoma, intestinal type of cardia, NOS
+∞
66.0
63
*
C16
ICD-10 Finland
Malignant neoplasm of stomach
+∞
65.0
62
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.0
64.5
225
503
UJD02
NOMESCO Finland
Gastroscopy
4.9
63.8
224
504
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
14.4
61.4
106
78
8936/3-C16.9
ICD-O-3
Gastrointestinal stromal tumor of stomach, NOS
+∞
60.8
58
*
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
8.8
60.5
134
162
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
16.5
59.0
96
61
8480/3-C16.9
ICD-O-3
Mucinous adenocarcinoma of stomach, NOS
+∞
57.6
55
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
6.0
56.7
166
301
C16.21
ICD-10 Finland
Malignant tumor of the corpus ventriculi early diffuse gastric carcinoma
+∞
56.5
54
*
8145/3-C16.2
ICD-O-3
Carcinoma, diffuse type of body of stomach
+∞
56.5
54
*
6322
FHL
Gastrectomy (including Roux-Y)
+∞
56.5
54
*
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
152.3
56.2
59
*
JN4CD
NOMESCO Finland
Very extensive body CT
5.3
55.0
178
364
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.7
54.3
165
313
A04AA55
ATC
palonosetron, combinations; systemic
10.7
53.9
107
106
8145/3-C16.0
ICD-O-3
Carcinoma, diffuse type of cardia, NOS
+∞
51.3
49
*
WZC30
NOMESCO Finland
Teaching
3.0
51.1
328
1224
JAH00
NOMESCO Finland
Laparotomy
6.6
51.1
137
221
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
66.5
50.5
58
9
9680/3-C16.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of stomach, NOS
+∞
50.2
48
*
WX600
NOMESCO Finland
Single shot through catheter
14.3
49.9
86
63
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
25.5
49.2
69
28
L01BC53
ATC
tegafur, combinations; systemic
92.7
49.1
54
6
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
14.1
48.6
84
62
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.6
48.0
128
205
B01AB05
ATC
enoxaparin; parenteral
2.2
47.8
652
3668
K29.4
ICD-10 Finland
Chronic atrophic gastritis
6.4
47.7
131
218
8140/3-C16.3
ICD-O-3
Adenocarcinoma, NOS, of gastric antrum
+∞
47.1
45
*
C16.5
ICD-10 Finland
Malignant neoplasm: Lesser curvature of stomach, unspecified
+∞
47.1
45
*
L03AA02
ATC
filgrastim; parenteral
6.5
46.8
127
208
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
46.2
622
3468
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
12.8
44.4
80
65
UJC12
NOMESCO Finland
Flexible oesophagoscopy
17.7
44.4
70
41
WW500
NOMESCO Finland
Blood transfusion
4.7
44.3
158
358
8240/3-C16.2
ICD-O-3
Neuroendocrine tumor, NOS, of body of stomach
+∞
43.9
42
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.6
43.2
158
367
8145/3-C16.3
ICD-O-3
Carcinoma, diffuse type of gastric antrum
+∞
42.9
41
*
8144/3-C16.2
ICD-O-3
Adenocarcinoma, intestinal type of body of stomach
+∞
42.9
41
*
C16.31
ICD-10 Finland
Malignant tumor of the antrum ventriculi early diffuse gastric carcinoma
+∞
42.9
41
*
JDW97
NOMESCO Finland
Other laparoscopic operation on stomach or duodenum
427.1
42.3
42
*
JDA63
NOMESCO Finland
Local excision of lesion of stomach
40.3
40.8
51
13
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
14.0
40.5
70
52
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
6.1
39.7
112
193
8144/3-C16.3
ICD-O-3
Adenocarcinoma, intestinal type of gastric antrum
+∞
39.7
38
*
WX402
NOMESCO Finland
General anaesthesia
2.6
39.6
322
1374
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
39.4
270
1037
JMA10
NOMESCO Finland
Transabdominal total splenectomy
22.2
38.5
56
26
B03BA02
ATC
cyanocobalamin tannin complex; parenteral
15.1
37.7
63
43
A04AD12
ATC
aprepitant; systemic
8.2
37.5
86
110
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
6.6
37.1
98
155
TPH07
NOMESCO Finland
Cathetrisation of artery
2.7
36.8
276
1120
9699/3-C16.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of stomach, NOS
+∞
36.6
35
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.1
36.2
215
750
JKA20
NOMESCO Finland
Cholecystectomy
4.7
36.1
127
283
C16.02
ICD-10 Finland
Malignant tumor of cardiac early intestinal gastric carcinoma
364.2
36.1
36
*
9591/3-C16.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of stomach, NOS
+∞
35.5
34
*
R11
ICD-10 Finland
Nausea and vomiting
3.2
35.1
200
677
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
10.7
34.7
68
66
384
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
+∞
34.5
33
*
JDC11
NOMESCO Finland
Laparoscopic partial gastrectomy and gastrojejunostomy
178.3
33.8
35
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
33.6
448
2423
ZX120
NOMESCO Finland
Intravenous
2.7
31.5
239
970
JDA55
NOMESCO Finland
Endoscopic dilatation of stomach, pylorus or anastomosis of stomach
25.0
31.5
44
18
L03AA13
ATC
pegfilgrastim; parenteral
4.6
30.3
110
253
C16.22
ICD-10 Finland
Malignant tumor of the corpus ventriculi early intestinal gastric carcinoma
+∞
30.3
29
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
30.3
503
2956
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
6.7
29.7
77
119
D64.9
ICD-10 Finland
Anaemia, unspecified
2.4
29.3
290
1357
C16.32
ICD-10 Finland
Malignant tumor of the antrum ventriculi early intestinal gastric carcinoma
+∞
29.2
28
*
C16.6
ICD-10 Finland
Malignant neoplasm: Greater curvature of stomach, unspecified
+∞
29.2
28
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
7.9
28.9
67
88
8140/3-C16.2
ICD-O-3
Adenocarcinoma, NOS, of body of stomach
+∞
28.2
27
*
K92.0
ICD-10 Finland
Haematemesis
4.4
28.1
105
249
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
7.7
27.7
65
87
K92.1
ICD-10 Finland
Melaena
3.0
27.5
171
612
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
6.3
27.4
74
121
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
27.4
368
1975
C16.19
ICD-10 Finland
Malignant tumor of the fundus ventriculi other or unspecified carcinoma
274.9
26.8
27
*
B01AB10
ATC
tinzaparin; parenteral
2.9
26.2
166
602
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
18.6
26.2
40
22
8000/3-C16.9
ICD-O-3
Neoplasm, malignant of stomach, NOS
+∞
26.1
25
*
JCC10
NOMESCO Finland
Transthoracic partial oesophagectomy without interposition
31.5
26.0
34
11
189
Kela drug reimbursment
Imatinib
24.4
25.7
36
15
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
6.8
24.6
63
96
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
15.7
24.6
40
26
K91.1
ICD-10 Finland
Postgastric surgery syndromes
43.5
24.6
30
7
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.7
24.5
112
319
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
5.2
24.4
77
153
C16.10
ICD-10 Finland
Malignant tumor of the fundus ventriculi without histology
+∞
24.0
23
*
C16.1
ICD-10 Finland
Malignant neoplasm: Fundus of stomach
+∞
24.0
23
*
K22.2
ICD-10 Finland
Oesophageal obstruction
8.1
24.0
54
68
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
5.0
23.4
76
156
JFF00
NOMESCO Finland
Catheter enterostomy
47.3
23.3
28
6
R13
ICD-10 Finland
Dysphagia
2.8
23.2
163
628
JDC97
NOMESCO Finland
Laparoscopic partial gastrectomy with other reconstruction
65.8
22.9
26
*
K25.3
ICD-10 Finland
Gastric ulcer, Acute without haemorrhage or perforation
9.6
22.6
46
49
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
7.3
22.4
54
76
C16.14
ICD-10 Finland
Malignant tumor of the fundus ventriculi intestinal carcinoma
+∞
21.9
21
*
JDD96
NOMESCO Finland
Total gastrectomy with other reconstruction
+∞
21.9
21
*
K25.4
ICD-10 Finland
Gastric ulcer, Chronic or unspecified with haemorrhage
7.1
21.5
53
77
A98
ICPC
Health maint/preventive medicine
0.6
21.1
1122
13206
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
5.8
20.9
60
107
376
Kela drug reimbursment
Cyanocobalamin
60.7
20.9
24
*
D00.2
ICD-10 Finland
Carcinoma in situ: Stomach
+∞
20.9
20
*
JFF01
NOMESCO Finland
Laparoscopic catheter enterostomy
+∞
20.9
20
*
L03AA14
ATC
lipegfilgrastim; parenteral
7.3
20.8
50
70
R18
ICD-10 Finland
Ascites
5.0
20.8
67
137
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.7
20.7
48
64
A09AA02
ATC
multienzymes (lipase, protease etc.)
4.6
20.6
73
165
ZXC86
NOMESCO Finland
Use of endoscopic device
12.6
20.4
36
29
A06AH03
ATC
naloxegol; oral
7.4
20.3
48
66
RD210
NOMESCO Finland
NA
6.2
19.9
54
90
C16.13
ICD-10 Finland
Malignant tumor of the fundus ventriculi diffuse carcinoma
+∞
19.8
19
*
8010/3-C16.9
ICD-O-3
Carcinoma, NOS, of stomach, NOS
+∞
19.8
19
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.0
19.8
264
1396
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
19.3
558
3817
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.8
19.0
127
475
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
55.6
18.9
22
*
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
10.8
18.9
36
34
1514C
ICD-9 Finland
Malignant neoplasm of stomach, Body of stomach[MAHASYÖPÄ, CORPORIS DIFFUUSI KARSINOOMA]
+∞
18.8
18
*
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
6.5
18.6
48
75
6321
FHL
Subtotal gastrectomy (also includes oment and spleen removal)
191.9
18.6
19
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
13.0
18.4
32
25
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.8
18.2
77
207
T91
ICPC
Vitamin/nutritional deficiency
7.9
18.1
41
53
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
15.5
18.0
29
19
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
33.2
18.0
23
7
R50.9
ICD-10 Finland
Fever, unspecified
2.0
17.7
262
1440
8480/3-C16.0
ICD-O-3
Mucinous adenocarcinoma of cardia, NOS
+∞
17.7
17
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
5.1
17.5
55
110
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
17.3
781
5945
L01XE01
ATC
[U] imatinib; oral
18.8
17.3
26
14
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
17.1
253
1392
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.4
16.8
50
94
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
16.8
249
1371
D70.82
ICD-10 Finland
Drug-induced neutropenia
5.3
16.7
51
99
D77
ICPC
Malignant digestive neopl other/NOS
13.5
16.5
28
21
JDE00
NOMESCO Finland
Gastrojejunostomy
18.1
16.5
25
14
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.0
16.2
96
334
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
3.9
15.7
64
167
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
26.5
15.6
21
8
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
85.8
15.6
17
*
B01AB04
ATC
dalteparin; parenteral
2.5
15.5
121
496
KA1FN
NOMESCO Finland
Isotope renography
10.9
15.5
29
27
316
Kela drug reimbursment
Imatinib
38.4
15.4
19
5
Z98.8
ICD-10 Finland
Other specified postsurgical states
6.0
15.0
41
70
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.0
15.0
86
293
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
14.8
161
777
6318
FHL
Resection (2/3) and gastrojejunostomy (including Roux-Y)
57.1
14.8
17
*
ZX121
NOMESCO Finland
Central venous catheter
16.6
14.8
23
14
TPX15
NOMESCO Finland
Removal of vascular injection port
9.8
14.7
29
30
JDA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in stomach or pylorus
36.3
14.4
18
5
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
27.4
14.3
19
7
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
14.2
148
704
A02BC05
ATC
esomeprazole; systemic
1.5
13.9
644
4861
-50
ICPC
Medication/prescr/renewal
2.6
13.9
101
399
A50
ICPC
General and Unspecified, Medication/prescr/renewal
3.1
13.7
76
254
A02BD07
ATC
lansoprazole, amoxicillin and clarithromycin; systemic
2.6
13.7
101
403
N02AX02
ATC
tramadol; systemic, rectal
1.5
13.6
735
5726
JDC96
NOMESCO Finland
Partial gastrectomy with other reconstruction
141.0
13.5
14
*
C15.1
ICD-10 Finland
Malignant neoplasm: Thoracic part of oesophagus
40.4
13.2
16
*
WF004
NOMESCO Finland
Palliative radiotherapy
3.5
13.0
61
180
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.4
13.0
106
448
C10AA05
ATC
atorvastatin; oral
0.7
12.8
390
5358
R4110
NOMESCO Finland
Physiotherapy
1.6
12.8
425
2961
RD160
NOMESCO Finland
NA
14.1
12.8
21
15
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
12.4
12.6
22
18
J01MA12
ATC
levofloxacin; systemic
1.6
12.4
362
2442
A55
ICPC
General and Unspecified, Local injection/infiltration
6.2
12.3
32
52
XX3DW
NOMESCO Finland
Time consuming IT work
1.9
12.3
178
968
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
9.7
12.2
24
25
C15.2
ICD-10 Finland
Malignant neoplasm: Abdominal part of oesophagus
37.8
12.2
15
*
JDH35
NOMESCO Finland
Endoscopic insertion of duodenal stent
47.0
11.9
14
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
14.7
11.8
19
13
15199
ICD-8 Finland
Malignant neoplasm of stomach, Part unspecified
+∞
11.5
11
*
8140/3-C16.4
ICD-O-3
Adenocarcinoma, NOS, of pylorus
+∞
11.5
11
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
4.0
11.4
45
116
A79
ICPC
Malignancy NOS
4.4
11.0
39
91
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.6
10.8
77
303
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
15.6
10.8
17
11
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.5
10.7
115
2028
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
6.7
10.7
26
39
D51.0
ICD-10 Finland
Vitamin B12deficiency anaemia due to intrinsic factor deficiency
5.5
10.6
30
55
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
10.1
10.5
20
20
JDA42
NOMESCO Finland
Other endoscopic haemostatic procedure in stomach or pylorus
7.4
10.5
24
33
UJF32
NOMESCO Finland
Coloscopy
1.5
10.5
437
3190
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.7
10.4
44
121
TJF00
NOMESCO Finland
Insertion of jejunal tube
32.7
10.3
13
*
V03AF03
ATC
calcium folinate; systemic
10.7
10.3
19
18
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
6.3
10.1
26
42
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.9
10.1
24
35
B50
ICPC
Blood and Immunity, Medication/prescr/renewal
11.3
10.1
18
16
K91.8
ICD-10 Finland
Other postprocedural disorders of digestive system, not elsewhere classified
40.3
10.0
12
*
WX002
NOMESCO Finland
Sedation and analgesia
1.5
9.9
326
2252
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.1
9.8
53
176
A02BX02
ATC
sucralfate; oral
2.2
9.8
103
490
JDA32
NOMESCO Finland
Endoscopic injection in stomach or pylorus
8.2
9.8
21
26
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
8.8
9.8
20
23
Z31.5
ICD-10 Finland
Genetic counselling
2.9
9.7
56
194
E34.0
ICD-10 Finland
Carcinoid syndrome
13.4
9.7
16
12
JCC30
NOMESCO Finland
Transthoracic partial oesophagectomy with interposition of intestine
55.3
9.6
11
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.7
9.5
62
233
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.3
9.5
46
142
C16.11
ICD-10 Finland
Malignant tumor of the fundus ventriculi early diffuse gastric carcinoma
+∞
9.4
9
*
8240/3-C16.0
ICD-O-3
Neuroendocrine tumor, NOS, of cardia, NOS
+∞
9.4
9
*
1512C
ICD-9 Finland
Malignant neoplasm of stomach, Pyloric antrum[MAHASYÖPÄ, ANTRI PYLORI DIFFUUSI KARSINOOMA]
+∞
9.4
9
*
8480/3-C16.3
ICD-O-3
Mucinous adenocarcinoma of gastric antrum
+∞
9.4
9
*
1514E
ICD-9 Finland
Malignant neoplasm of stomach, Body of stomach[MAHASYÖPÄ, CORPORIS MUU TARK MÄÄR CA]
+∞
9.4
9
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
5.1
9.3
28
56
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
13.7
9.2
15
11
A02BD03
ATC
lansoprazole, amoxicillin and metronidazole; systemic
1.9
9.0
138
766
JFA65
NOMESCO Finland
Endoscopic insertion of ileum stent
24.1
8.9
12
5
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
8.9
282
1931
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
4.4
8.7
30
69
JFC00
NOMESCO Finland
Entero-enterostomy
14.1
8.7
14
10
JCA08
NOMESCO Finland
Endoscopic removal of foreign body from oesophagus
9.0
8.5
17
19
S50
ICPC
Skin, Medication/prescr/renewal
5.4
8.4
24
45
1505A
ICD-9 Finland
Malignant neoplasm of oesophagus, Lower third of oesophagus
90.5
8.4
9
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.3
8.4
73
320
D50.8
ICD-10 Finland
Other iron deficiency anaemias
3.5
8.4
37
107
8145/3-C16.4
ICD-O-3
Carcinoma, diffuse type of pylorus
+∞
8.3
8
*
8936/3-C16.2
ICD-O-3
Gastrointestinal stromal tumor of body of stomach
+∞
8.3
8
*
1510E
ICD-9 Finland
Malignant neoplasm of stomach, Cardia[MAHASYÖPÄ,KARDIA,MUU TARK MÄÄR CA]
+∞
8.3
8
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
10.8
8.3
15
14
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
3.7
8.2
34
93
N40
ICD-10 Finland
Hyperplasia of prostate
0.7
8.2
308
4132
-55
ICPC
Local injection/infiltration
5.2
8.2
24
47
I10
ICD-10 Finland
Essential (primary) hypertension
0.8
8.1
792
9206
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.5
8.1
27
61
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
7.8
7.9
17
22
B82
ICPC
Anaemia other/unspecified
2.7
7.8
51
193
JFB40
NOMESCO Finland
Resection of transverse colon
10.8
7.8
14
13
JLC10
NOMESCO Finland
Distal pancreatectomy
9.4
7.8
15
16
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.2
7.8
74
339
XX_20
NOMESCO Finland
Bioimpedance measurement
45.2
7.7
9
*
JCC00
NOMESCO Finland
Transhiatal partial oesophagectomy without interposition
25.1
7.6
10
*
RD130
NOMESCO Finland
NA
25.1
7.6
10
*
C10AA07
ATC
rosuvastatin; oral
0.7
7.5
193
2782
JN6AD
NOMESCO Finland
CT of torso and neck
4.1
7.5
27
66
N06DA02
ATC
donepezil; oral
0.4
7.5
33
780
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
3.6
7.5
31
86
1514A
ICD-9 Finland
Malignant neoplasm of stomach, Body of stomach[MAHASYÖPÄ, CORPORIS EARLY DIFF GASTR CA]
80.4
7.4
8
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.4
7.4
33
775
WX704
NOMESCO Finland
Intubation
1.9
7.3
104
565
JD003
NOMESCO Finland
Adjuvant radiotherapy of gastric or duodenal tumor
+∞
7.3
7
*
1510A
ICD-9 Finland
Malignant neoplasm of stomach, Cardia[MAHASYÖPÄ,KARDIA,EARLY DIFF GASTR CA]
+∞
7.3
7
*
8010/3-C16.0
ICD-O-3
Carcinoma, NOS, of cardia, NOS
+∞
7.3
7
*
8000/3-C16.0
ICD-O-3
Neoplasm, malignant of cardia, NOS
+∞
7.3
7
*
1518A
ICD-9 Finland
Malignant neoplasm of stomach, Other specified sites of stomach[MAHASYÖPÄ, ALIA DEFINITA,EARLY DIFF GASTR CA]
+∞
7.3
7
*
XF612
NOMESCO Finland
Measurement of central venous pressure
9.4
7.3
14
15
C08CA01
ATC
amlodipine; oral
0.7
7.3
423
5316
M01AH05
ATC
etoricoxib; oral
0.7
7.2
524
6381
C15.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of oesophagus
20.1
7.1
10
5
N02AA01
ATC
morphine; systemic, rectal
3.1
7.1
36
117
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
6.0
7.1
18
30
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
7.0
7.0
16
23
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
4.9
7.0
21
43
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
13.8
6.9
11
8
M79.6
ICD-10 Finland
Pain in limb
0.7
6.9
283
3756
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.3
6.9
18
524
N05AD01
ATC
haloperidol; systemic
2.1
6.8
71
343
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
4.5
6.8
22
49
WW200
SPAT
NA
0.4
6.7
31
718
K31.1
ICD-10 Finland
Adult hypertrophic pyloric stenosis
16.7
6.7
10
6
JD1AB
NOMESCO Finland
Gastro-duodenography with X-ray
22.6
6.7
9
*
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
0.6
6.5
122
1880
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.9
6.5
94
514
UJD10
SPAT
NA
3.8
6.5
25
66
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
6.2
6.5
16
26
JDE01
NOMESCO Finland
Laparoscopic gastroenterostomy
70.1
6.4
7
*
15181
ICD-8 Finland
Malignant neoplasm of stomach, Fundi sive corporis ventriculi
70.1
6.4
7
*
JDC00
NOMESCO Finland
Partial gastrectomy and gastroduodenostomy
70.1
6.4
7
*
N05BA06
ATC
lorazepam; systemic, sublingual
1.9
6.4
91
495
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
3.9
6.4
24
62
D50
ICD-10 Finland
Iron deficiency anaemia
3.4
6.3
28
83
K29.7
ICD-10 Finland
Gastritis, unspecified
2.2
6.3
57
258
N06DX01
ATC
memantine; oral
0.5
6.3
48
937
8249/3-C16.2
ICD-O-3
Neuroendocrine tumor, grade 2 of body of stomach
+∞
6.3
6
*
8490/3-C16.2
ICD-O-3
Signet ring cell carcinoma of body of stomach
+∞
6.3
6
*
8480/3-C16.2
ICD-O-3
Mucinous adenocarcinoma of body of stomach
+∞
6.3
6
*
8249/3-C16.9
ICD-O-3
Neuroendocrine tumor, grade 2 of stomach, NOS
+∞
6.3
6
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.6
6.2
103
1631
JDW96
NOMESCO Finland
Other operation on stomach or duodenum
26.8
6.2
8
*
N03AX16
ATC
pregabalin; oral
1.4
6.2
330
2498
R83
ICPC
Respiratory infection other
0.6
6.2
85
1405
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
3.9
6.2
23
59
SPAT1255
SPAT
Intravenous administration of medicine
1.7
6.2
113
670
R63.4
ICD-10 Finland
Abnormal weight loss
2.2
6.2
61
288
WVA30
SPAT
NA
2.5
6.2
44
177
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
7.7
6.1
13
17
L01BC04
ATC
carmofur; oral
12.6
6.1
10
8
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.7
6.1
37
137
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
8.6
6.1
12
14
JWW96
NOMESCO Finland
Other reoperation in gastroenterological surgery
10.1
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
798
1708
7.19
307.65
6.0
3.9
ug/l
28.2
19.3
0.53
726
1435
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
429
591
9.01
306.52
5.6
3.1
u/ml
923.4
7358.9
0.75
389
498
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
314
328
11.21
276.24
4.4
3.1
u/ml
161.7
1207.8
0.73
293
302
(40768797) Stomach Pathology biopsy report
724
1894
5.48
270.90
2.1
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
534
1450
4.69
183.45
3.3
2.1
g/l
0.2
0.2
0.06
512
1340
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
118
50
25.05
166.26
1.0
1.1
—
—
—
0
0
(4035726)
445
1232
4.38
146.41
1.8
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
587
2570
2.83
88.86
4.1
3.0
mmol/l
0.8
0.8
0.75
561
2392
(3024561) Albumin [Mass/volume] in Serum or Plasma
1087
6743
2.37
75.34
10.1
4.7
g/l
32.5
34.5
23.66
1044
6221
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
811
4597
2.30
67.28
3.4
2.5
u/l
61.6
58.2
0.72
764
4216
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1156
7779
2.18
60.48
14.2
6.1
umol/l
11.5
12.4
1.75
1129
7360
(3003458) Phosphate [Moles/volume] in Serum or Plasma
454
2173
2.42
53.78
5.0
5.4
mmol/l
1.0
1.0
1.55
434
1990
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
373
1663
2.54
51.33
3.9
2.6
umol/l
9.7
10.0
0.06
340
1461
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
703
4178
2.06
47.86
2.7
2.2
mg/l
3.5
3.1
3.58
637
3500
(3014576) Chloride [Moles/volume] in Serum or Plasma
428
2111
2.31
46.64
10.2
6.7
mmol/l
104.9
104.3
1.55
421
2055
(3044640) Blood type and Crossmatch panel - Blood
762
4727
2.00
45.50
3.8
2.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
482
2579
2.15
42.56
2.5
2.5
umol/l
11.1
12.2
2.03
450
2361
(3032080) INR in Blood by Coagulation assay
985
6870
1.87
39.70
9.1
11.4
inr
1.3
1.4
3.58
261
1867
(3004789) Transferrin [Mass/volume] in Serum or Plasma
438
2380
2.08
36.47
2.4
2.5
g/l
2.4
2.3
6.20
412
2178
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
290
1343
2.36
35.83
4.7
2.4
u/l
37.6
38.7
0.09
263
1139
(3000570) Elastase.pancreatic [Mass/mass] in Stool
137
434
3.32
35.02
1.7
1.5
ug/g
231.3
271.7
1.84
109
266
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
949
6751
1.79
33.97
5.6
4.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
741
4903
1.82
33.80
5.6
4.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
512
3023
1.94
33.33
6.6
3.1
mmol/l
2.5
2.5
0.20
482
2638
(3013650) Neutrophils [#/volume] in Blood by Automated count
1078
7994
1.77
33.13
15.5
8.7
e9/l
4.2
4.4
0.85
986
6937
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
587
3641
1.87
32.77
3.5
2.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1086
13472
0.57
32.38
4.3
5.3
mmol/l
2.4
2.6
6.38
956
12120
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
409
2264
2.02
31.91
2.4
2.6
%
18.9
22.1
2.92
350
1915
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
662
4302
1.81
31.56
5.0
3.1
u/l
40.6
39.5
0.08
642
4079
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1052
13099
0.58
30.74
3.9
4.7
mmol/l
4.3
4.4
3.80
928
11879
(3015377) Calcium [Moles/volume] in Serum or Plasma
750
5102
1.76
30.32
6.2
3.3
mmol/l
2.3
2.3
6.43
701
4368
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1042
12963
0.58
29.65
3.9
4.6
mmol/l
1.5
1.4
2.33
903
11632
(3020779) Urea [Moles/volume] in Serum or Plasma
300
1542
2.12
28.34
4.9
6.6
mmol/l
8.7
11.2
7.00
281
1460
(3033658) Prothrombin time (PT) actual/Normal
582
3741
1.79
28.16
6.0
4.0
%
84.1
83.5
0.24
575
3648
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
251
1213
2.23
27.69
1.6
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
795
5648
1.69
26.49
3.4
2.8
ug/l
98.3
162.3
12.86
744
5078
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1055
12824
0.62
23.71
6.7
6.5
mmol/mol
41.3
41.1
0.37
949
11655
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1028
12554
0.62
23.34
3.6
4.2
mmol/l
1.2
1.3
2.65
890
11177
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
925
7065
1.59
21.60
8.2
6.0
mmol/l
1.2
1.2
3.01
876
6348
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
992
7761
1.56
20.45
9.2
6.8
mmol/l
1.2
1.2
4.29
823
6489
(3028717) Thiamine [Mass/volume] in Blood
16
10
16.12
18.52
1.3
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
142
648
2.28
17.81
2.4
2.5
u/ml
0.3
0.3
0.09
76
370
(3002256) Pathology report gross observation
307
1846
1.79
17.68
1.5
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1023
12202
0.66
17.47
4.8
4.5
mu/l
2.0
2.1
0.69
912
10867
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
319
1967
1.74
16.78
3.7
3.9
u/l
234.0
248.6
1.01
300
1840
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1144
13287
0.67
16.46
4.6
5.0
mmol/l
6.1
6.1
0.13
1025
11800
(3018418) pH of Serum or Plasma
627
4600
1.53
16.22
5.5
4.1
ph
7.4
7.4
0.18
155
885
(3027945) Reticulocytes/100 erythrocytes in Blood
332
2102
1.70
15.81
2.0
2.3
%
1.7
1.8
0.83
296
1833
(4281824)
46
120
3.90
15.77
1.2
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
177
925
2.00
15.65
11.5
9.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
707
5407
1.48
14.62
2.8
2.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1331
14864
0.67
13.91
45.5
25.4
g/l
120.0
133.5
157.97
1297
14529
(3026361) Erythrocytes [#/volume] in Blood
1331
14861
0.67
13.86
45.2
25.2
e12/l
4.1
4.4
73.69
1280
14321
(3035941) MCH [Entitic mass]
1331
14860
0.67
13.84
44.9
25.1
pg
29.8
30.5
25.19
1301
14525
(3024731) MCV [Entitic volume]
1331
14859
0.68
13.82
45.0
25.1
fl
90.8
91.8
8.56
1301
14526
(3007461) Platelets [#/volume] in Blood
1331
14858
0.68
13.80
45.2
25.2
e9/l
257.2
238.1
14.64
1285
14373
(3002173) Hemoglobin [Mass/volume] in Arterial blood
266
1642
1.72
13.79
10.5
7.6
g/l
113.8
121.0
7.81
257
1579
(3003694) ABO and Rh group [Type] in Blood
475
3379
1.54
13.78
1.3
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1332
14866
0.68
13.78
45.2
25.3
e9/l
7.3
6.9
1.89
1279
14316
(40758558) Short blood count panel - Blood
490
3515
1.53
13.66
12.1
6.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
544
7110
0.67
13.17
4.1
5.3
ug/l
3.7
4.1
0.13
471
6278
(3000991) Gas panel - Venous blood
234
1419
1.74
12.90
10.7
8.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
638
4875
1.46
12.87
4.9
5.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
251
1556
1.70
12.77
2.0
2.5
e9/l
63.0
68.2
1.54
193
1202
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
417
5712
0.66
12.66
3.8
4.6
%
21.2
21.9
0.40
195
2946
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
36
93
3.92
12.55
1.4
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
280
1816
1.63
11.95
10.1
7.2
%
96.1
95.1
2.46
269
1743
(3021960) Folate [Moles/volume] in Serum or Plasma
525
3910
1.47
11.94
1.8
1.6
nmol/l
22.3
19.9
3.12
478
3305
(3014111) Lactate [Moles/volume] in Serum or Plasma
240
1500
1.68
11.82
9.4
6.7
mmol/l
1.3
1.4
0.57
234
1441
(3023487) Leukocytes [#/volume] in Peritoneal fluid
27
59
4.63
11.66
1.7
2.4
e6/l
704.1
851.2
0.17
16
50
(3003396) Base excess in Arterial blood by calculation
302
2021
1.58
11.29
9.7
6.9
mmol/l
0.9
1.2
0.68
249
1552
(3027801) Oxygen [Partial pressure] in Arterial blood
301
2021
1.58
11.08
9.8
6.9
kpa
12.8
11.6
3.40
287
1913
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
301
2021
1.58
11.08
9.8
6.9
kpa
5.2
5.1
0.51
286
1912
(3019069) Monocytes/100 leukocytes in Blood
803
6526
1.39
11.02
5.5
6.0
%
9.3
9.0
1.08
768
6057
(3006504) Eosinophils/100 leukocytes in Blood
799
6502
1.39
10.82
5.3
5.8
%
2.4
2.8
7.13
764
6011
(1761868) Lipid panel - Serum or Plasma
272
3957
0.64
10.62
3.0
3.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
812
6642
1.38
10.59
5.5
6.0
%
23.6
25.8
5.73
771
6129
(3022096) Basophils/100 leukocytes in Blood
778
6321
1.38
10.57
5.3
5.7
%
0.6
0.6
0.08
745
5851
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
467
3476
1.45
10.45
2.0
1.7
pmol/l
477.3
18482156.7
1.88
387
2819
(3042936) Bacteria identified in Isolate by Culture
325
2255
1.53
10.29
2.1
2.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1050
8986
1.36
10.13
7.6
4.9
mmol/l
6.8
6.9
1.67
1020
8480
(3004809) Band form neutrophils/100 leukocytes in Blood
67
285
2.40
9.95
2.3
3.9
%
2.0
1.7
0.29
51
221
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
91
441
2.12
9.91
3.2
3.5
u/ml
85.0
65.4
0.34
91
423
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
23
51
4.55
9.78
1.7
2.1
e6/l
9244.7
32843.6
—
9
34
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1262
11149
1.37
9.77
16.0
7.6
u/l
103.5
81.3
14.45
1222
10429
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
286
4050
0.66
9.71
2.6
3.2
ug/l
0.8
0.8
0.18
205
2838
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
169
1017
1.72
9.54
1.6
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
829
6882
1.35
9.53
5.0
5.5
e9/l
0.0
0.0
0.11
711
5874
(3019198) Lymphocytes [#/volume] in Blood
842
7008
1.35
9.51
5.1
5.6
e9/l
1.7
1.9
3.72
737
6088
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1304
14341
0.73
9.40
19.3
11.0
u/l
27.2
25.9
0.37
1268
13698
(3033799) Differential panel - Peritoneal fluid
22
49
4.53
9.31
1.6
2.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
823
6849
1.35
9.21
5.0
5.5
e9/l
0.7
0.6
1.74
707
5838
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
841
9840
0.75
9.07
4.2
3.6
pmol/l
14.8
15.0
1.60
757
8730
(3019309) Folate [Moles/volume] in Red Blood Cells
455
3455
1.41
8.95
2.0
1.8
nmol/l
1192.7
1173.9
0.16
364
2566
(3021440) Promyelocytes/100 leukocytes in Blood
182
1138
1.66
8.91
3.2
4.2
%
0.1
0.1
0.48
89
370
(3017181) Myelocytes/100 leukocytes in Blood
190
1212
1.63
8.60
3.2
4.1
%
1.1
0.9
0.58
96
403
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
92
474
1.99
8.53
1.7
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
173
1085
1.65
8.38
3.1
4.0
%
0.7
0.6
0.24
65
290
(3018010) Neutrophils/100 leukocytes in Blood
781
6519
1.33
8.31
5.3
5.7
%
59.6
58.8
0.78
744
6051
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
531
6591
0.73
8.28
2.4
2.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1271
13942
0.75
8.17
29.0
16.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
356
4694
0.70
8.02
3.0
3.3
mg/l
806.0
281.4
0.78
230
3068
(3023103) Potassium [Moles/volume] in Serum or Plasma
1327
14449
0.75
7.93
35.8
20.8
mmol/l
4.0
4.0
10.91
1286
13999
(3019550) Sodium [Moles/volume] in Serum or Plasma
1326
14423
0.75
7.71
35.6
20.6
mmol/l
138.9
139.6
17.77
1288
13992
(3020682) Albumin/Creatinine [Ratio] in Urine
384
4972
0.72
7.71
3.7
4.0
mg/mmol
17.7
9.0
0.59
243
3219
(3013115) Eosinophils [#/volume] in Blood
836
7110
1.31
7.56
5.4
5.7
e9/l
0.2
0.2
4.76
729
6168
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
194
1284
1.57
7.53
4.6
4.1
mmol/l
1.2
1.2
0.68
180
1121
(40760892) CBC W Ordered Manual Differential panel - Blood
365
2749
1.40
7.39
4.5
4.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
255
3521
0.68
7.35
1.7
1.6
mmol/l
1.3
1.4
0.54
216
2907
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
63
299
2.14
7.31
1.7
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
36
136
2.68
6.91
1.3
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1156
12738
0.77
6.88
31.2
16.5
ml/min/173m2
79.5
73.5
18.08
1038
10618
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
75
390
1.96
6.83
1.7
1.6
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
18
45
4.03
6.62
1.8
2.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
127
783
1.67
6.60
2.0
1.9
ug/l
3.5
2.4
0.34
114
681
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
95
545
1.78
6.40
1.3
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
55
263
2.12
6.31
2.9
3.2
e9/l
4.1
4.5
0.39
55
263
(3052592) Norovirus Ag [Presence] in Stool
15
34
4.44
6.24
1.5
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
228
1626
1.46
6.20
3.6
3.5
mmol/l
2.3
2.0
0.44
175
1278
(3009508) Creatinine [Moles/volume] in Urine
379
4770
0.75
6.07
2.9
3.2
mmol/l
7.4
7.4
0.04
294
3923
(3006653) Thiamine [Moles/volume] in Blood
24
79
3.06
5.92
1.3
1.2
nmol/l
122.9
133.7
0.78
24
79
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
9
334
0.27
5.60
1.3
1.8
nmol/l
65.8
42.6
—
9
315
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
131
851
1.58
5.55
1.4
1.8
g/l
1.5
1.5
0.15
117
726
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
55
277
2.01
5.54
3.8
3.6
%
58.4
59.8
0.27
55
277
(3025159) Blasts/100 leukocytes in Blood
156
1058
1.52
5.46
3.4
4.2
%
0.0
0.4
0.73
71
310
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
168
1158
1.49
5.44
1.3
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
224
1635
1.42
5.37
3.6
3.5
kpa
5.7
5.8
1.31
218
1577
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
759
6580
1.25
5.30
2.5
2.1
pmol/l
84.3
92.0
5.58
511
3533
(3017143) Hepatitis C virus Ab [Presence] in Serum
161
1112
1.49
5.17
1.3
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
110
699
1.61
5.13
1.2
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
446
0.31
5.12
1.6
1.5
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
6
13.38
5.08
1.0
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
39
178
2.22
5.08
1.7
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
39
178
2.22
5.08
1.7
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
39
178
2.22
5.08
1.7
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
985
10881
0.81
5.05
41.3
22.8
g/l
327.0
331.7
39.75
967
10739
(3005988) Vibrio sp identified in Specimen by Organism specific culture
39
179
2.20
5.01
1.7
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
39
179
2.20
5.01
1.7
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
68
1160
0.57
4.98
1.6
2.2
nmol/l
13.8
12.5
0.44
60
994
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
39
180
2.19
4.95
1.7
1.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
187
1352
1.42
4.74
3.3
2.9
kpa
4.3
4.5
0.38
180
1299
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
6
251
0.24
4.61
1.2
2.0
pmol/l
185.8
214.0
—
6
233
(3010421) pH of Blood
79
477
1.68
4.53
2.8
4.7
ph
7.4
7.4
0.04
63
398
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
43
214
2.03
4.53
1.5
1.7
ug/l
16.0
26.0
0.89
43
209
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
19
65
2.94
4.44
1.1
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
41
204
2.03
4.34
1.7
2.2
u/ml
384.9
27.7
0.64
41
196
(40768795) Lymph node Pathology biopsy report
29
126
2.32
4.27
1.1
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
45
233
1.95
4.27
1.3
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
431
0.37
4.22
1.7
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
132
1862
0.69
4.18
3.5
4.7
%
34.9
32.8
1.44
88
1219
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
132
1861
0.69
4.16
1.2
1.2
u/ml
41.4
15.3
0.35
45
662
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
34
674
0.50
4.14
1.5
1.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
23
91
2.55
4.13
1.1
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
154
1105
1.43
4.10
8.2
6.3
mmol/l
24.9
24.5
0.58
143
1031
(3022145) Colonoscopy Study observation
196
1473
1.37
3.98
1.3
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
567
4884
1.23
3.96
3.5
3.5
e6/l
101.2
97.2
0.02
451
3872
(3009542) Hematocrit [Volume Fraction] of Blood
1098
11860
0.83
3.92
32.9
18.7
%
35.5
38.7
19.42
683
7412
(3019060) Gas panel - Arterial blood
163
1193
1.40
3.89
5.6
4.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
31
145
2.16
3.87
1.2
1.2
u/l
52.3
52.7
0.02
23
95
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
405
4814
0.80
3.86
2.1
2.2
u/l
359.1
227.9
0.37
379
4494
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
73
452
1.64
3.85
1.3
1.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
164
1206
1.39
3.81
2.6
2.1
nmol/l
394.0
373.0
0.68
155
1083
(46235355) HIV 1 and 2 tests - Meaningful Use set
179
1336
1.37
3.80
1.4
1.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
65
393
1.68
3.76
2.0
2.3
g/l
3.6
3.7
0.03
60
371
(3039443) Prostate specific Ag panel - Serum or Plasma
9
268
0.33
3.70
1.7
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
111
768
1.47
3.61
1.2
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
82
532
1.56
3.59
6.2
5.4
mmol/l
1.4
1.4
0.14
71
466
(3025941) Bacteria identified in Stool by Culture
101
688
1.49
3.55
1.4
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
42
228
1.86
3.52
1.4
1.5
—
—
—
0
0
(3039000) Anion gap in Blood
63
387
1.65
3.46
7.0
5.9
mmol/l
10.8
11.3
0.73
54
347
(3018572) Chloride [Moles/volume] in Blood
63
387
1.65
3.46
7.0
5.9
mmol/l
106.0
105.4
0.45
54
347
(3000492) Spirometry study
151
1118
1.38
3.39
1.5
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
315
2585
1.26
3.38
3.3
3.1
e6/l
2.7
1.7
0.68
191
1481
(3012501) Base excess in Blood by calculation
65
406
1.62
3.35
3.0
5.1
mmol/l
2.6
2.6
0.05
44
278
(3000475) Leukocytes [#/volume] in Synovial fluid
16
385
0.41
3.33
1.8
1.7
e6/l
3261.2
17748.6
—
10
275
(3026782) Osmolality of Urine
390
3299
1.23
3.18
3.0
2.9
mosm/kgh2o
550.8
559.8
0.37
347
2804
(3037692) Legionella sp identified in Specimen by Organism specific culture
15
55
2.74
3.15
1.1
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
509
4425
1.20
3.14
3.4
3.4
e6/l
1.1
0.5
1.60
395
3451
(3017354) Segmented neutrophils/100 leukocytes in Blood
34
180
1.90
3.10
2.0
3.9
%
58.6
57.8
0.07
17
122
(3013727) Leukocytes other/100 leukocytes in Blood
15
56
2.69
3.06
2.1
4.1
%
52.3
51.8
0.03
15
51
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
15
56
2.69
3.06
1.0
2.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
117
847
1.41
3.03
2.3
2.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
624
5560
1.18
2.88
2.5
2.2
nmol/l
75.9
78.1
1.09
575
4832
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
214
1715
1.28
2.81
5.7
3.8
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
11
36
3.07
2.81
2.9
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
327
0.42
2.76
1.6
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
25
124
2.03
2.76
1.3
1.6
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
101
727
1.41
2.73
5.6
4.6
%
1.7
1.7
0.01
92
681
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
111
813
1.39
2.71
3.9
3.5
mmol/l
23.6
24.0
0.54
104
727
(3013707) Erythrocyte sedimentation rate by Westergren method
959
10310
0.86
2.69
4.2
4.1
mm/h
15.5
14.3
1.33
876
9409
(3044889) 12 lead EKG panel
933
10048
0.86
2.67
4.9
4.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
26
133
1.97
2.65
1.1
1.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
99
717
1.40
2.60
5.7
4.6
%
0.9
0.9
0.19
90
673
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
13
303
0.43
2.57
1.2
1.2
u/l
51.2
42.1
0.22
13
259
(3026493) Urate [Moles/volume] in Serum or Plasma
345
4010
0.83
2.53
3.2
2.9
umol/l
3567.5
6967.5
0.74
293
3374
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
19
88
2.17
2.51
2.6
3.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
17
75
2.28
2.51
1.6
2.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
40
241
1.67
2.45
2.6
2.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
17
76
2.25
2.44
1.4
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
17
76
2.25
2.44
1.4
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
21
103
2.05
2.42
1.3
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
12
5.01
2.40
2.0
3.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
17
77
2.22
2.37
1.6
2.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
21
104
2.03
2.36
1.3
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
18
85
2.13
2.29
2.6
2.8
%
40.2
37.7
—
6
32
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
6
13
4.63
2.27
5.3
6.3
umol/l
0.2
0.3
—
6
13
(36304419) Bacteria [Presence] in Urine
479
4251
1.17
2.26
3.3
3.4
—
—
—
0
0
(1002224) Polysomnography panel
19
366
0.51
2.26
1.1
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
60
0.00
2.24
0.0
1.2
—
38.2
—
0
31
(3020891) Body temperature
94
698
1.36
2.17
5.4
4.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
604
5469
1.15
2.17
4.0
3.9
e6/l
163.0
122.8
0.24
461
4109
(3004451) EKG impression Narrative
19
94
2.03
2.16
1.1
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1021
10837
0.88
2.15
39.0
21.0
%
15.2
13.9
68.41
998
10552
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
37
228
1.63
2.12
1.4
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
45
293
1.55
2.06
8.7
5.0
iu/ml
211.1
906.8
—
10
41
(3021788) Differential panel - Synovial fluid
14
288
0.48
2.04
1.8
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
20
366
0.54
2.04
1.3
1.7
mg/l
8.4
3.1
1.00
15
280
(3007853) Bacteria identified in Skin by Aerobe culture
215
1796
1.22
2.01
1.8
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
18
90
2.01
2.00
1.3
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
18
90
2.01
2.00
1.3
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
29
171
1.71
1.97
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
191
1582
1.23
1.94
4.1
4.5
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
16
3.76
1.93
1.2
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
883
8247
1.13
1.93
3.6
3.2
u/l
76.3
57.6
2.24
819
7537
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
159
1941
0.80
1.92
1.2
1.2
iu/ml
33.7
39.3
0.16
44
618
(3008898) HLA-B27 [Presence]
14
278
0.50
1.87
1.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
17
3.54
1.84
3.0
2.5
u/field
0.8
0.7
—
6
17
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1315
13671
0.88
1.80
30.7
17.4
mg/l
36.9
27.7
15.45
1207
11236
(3023199) Leukocytes [#/volume] in Pleural fluid
40
263
1.53
1.79
1.3
1.4
e6/l
1436.6
1514.0
0.08
29
189
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
26
425
0.61
1.79
1.5
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
37
240
1.55
1.76
1.4
1.4
e6/l
13375.2
87208.5
1.74
23
143
(3043409) Potassium [Moles/volume] in Arterial blood
71
526
1.36
1.72
5.2
3.9
mmol/l
3.8
4.0
3.37
65
484
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
13
3.85
1.71
1.0
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
13
3.85
1.71
1.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
13
3.85
1.71
1.0
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
46
0.00
1.70
0.0
1.8
—
190.3
—
0
40
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
47
0.00
1.70
0.0
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
16
82
1.96
1.69
1.6
2.0
%
9.8
16.4
—
6
32
(3008757) Leukocyte morphology finding [Identifier] in Blood
30
187
1.61
1.69
2.4
4.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
86
659
1.32
1.67
1.9
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
13
253
0.51
1.66
1.1
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
25
2.81
1.65
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
29
181
1.61
1.63
1.1
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
327
2890
1.16
1.63
1.9
1.9
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
113
1.78
1.60
1.3
1.5
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
20
3.01
1.58
1.0
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
24
144
1.67
1.57
1.3
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
39
264
1.49
1.56
3.3
2.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
40
576
0.69
1.56
1.2
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
18
100
1.81
1.53
1.9
2.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
40
274
1.47
1.52
1.4
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
6
142
0.42
1.52
1.2
1.6
—
1568.0
—
0
5
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
98
1225
0.79
1.50
1.5
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
20
116
1.73
1.49
1.1
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
13
65
2.01
1.48
3.1
2.8
u/l
195.5
215.1
0.75
13
65
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
9
37
2.44
1.48
2.7
3.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
37
2.44
1.48
1.4
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
52
377
1.39
1.47
1.2
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
16
88
1.82
1.41
2.2
2.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
518
4763
1.12
1.41
3.2
3.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
10
46
2.18
1.40
1.0
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
32
469
0.68
1.40
1.4
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
52
381
1.37
1.39
1.2
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
40
281
1.43
1.36
1.4
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
31
207
1.51
1.35
1.4
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
19
309
0.61
1.34
1.6
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
52
384
1.36
1.34
1.2
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
61
1.97
1.33
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
61
1.97
1.33
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
24
152
1.59
1.32
1.4
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
32
218
1.48
1.28
1.3
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
146
1235
1.20
1.27
3.7
4.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
90
724
1.25
1.27
2.0
2.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
108
887
1.23
1.27
3.0
3.1
e9/l
4.7
4.2
0.56
80
644
(3017704) Immunofixation for Urine
5
117
0.43
1.25
1.6
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
70
1.86
1.24
2.4
2.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
263
2947
0.88
1.23
1.6
1.7
mg/l
2.2
1.5
2.08
215
2300
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
304
2731
1.13
1.22
3.2
2.9
e6/l
1.4
1.1
0.65
180
1621
(3034770) Mitochondria Ab [Titer] in Serum
46
339
1.37
1.22
1.2
1.2
—
806.3
—
0
8
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
19
2.64
1.21
8.2
9.2
mmol/l
4.3
5.7
—
5
19
(3000850) Epithelial cells [#/volume] in Urine
382
3482
1.12
1.21
2.6
2.7
e6/l
5.3
4.7
0.57
339
3078
(3000034) Microalbumin [Mass/volume] in Urine
21
132
1.60
1.20
1.8
3.0
mg/l
15.1
31.1
0.66
14
106
(3020630) Protein [Mass/volume] in Serum or Plasma
172
1486
1.17
1.19
2.1
2.6
g/l
62.1
66.2
7.94
159
1338
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
38
2.11
1.18
1.6
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
34
0.00
1.16
0.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
13
223
0.58
1.15
1.0
1.1
—
26.3
—
0
16
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
20
2.50
1.15
1.4
1.6
ng/l
225.8
138.8
—
5
20
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
36
0.00
1.14
0.0
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
65
1.85
1.13
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
209
0.57
1.13
1.3
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
33
234
1.42
1.11
1.5
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
41
1.96
1.08
1.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
9
164
0.55
1.08
1.7
1.9
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
32
2.19
1.08
1.9
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
47
356
1.33
1.07
3.0
2.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
186
1.46
1.06
1.4
1.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
47
357
1.32
1.06
1.8
2.6
umol/l
30.2
37.3
0.89
38
290
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
34
245
1.39
1.06
1.3
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
12
67
1.80
1.04
1.4
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
32
440
0.72
1.04
1.1
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
494
5292
0.91
1.04
2.9
3.2
ng/l
1925.9
1948.6
0.04
446
4558
(21494814) CD8 cells/100 lymphocytes in Specimen
9
46
1.96
1.03
1.4
1.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
264
0.64
1.03
1.9
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
22
2.28
1.03
1.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
27
188
1.44
1.01
1.2
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
10
53
1.89
1.01
1.2
2.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
21
310
0.67
1.01
1.0
1.2
u/ml
2.0
4.0
—
5
28
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
51
396
1.30
1.00
1.6
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
18
116
1.56
0.96
1.7
2.0
e9/l
1.3
1.0
0.50
13
66
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
31
0.00
0.96
0.0
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
226
2030
1.13
0.94
1.9
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
14
85
1.65
0.94
1.1
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
136
1562
0.86
0.93
1.2
1.3
titre
473.9
448.4
0.06
33
341
(3051651) Icteric interference index of Serum or Plasma
15
93
1.62
0.93
8.5
3.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
27
2.23
0.93
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
144
0.55
0.93
4.4
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
21
142
1.48
0.92
1.4
1.6
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
10
55
1.82
0.92
1.6
1.7
ug/l
70.2
54.9
—
10
50
(3045424) Erythrocytes [Presence] in Urine
14
220
0.63
0.92
1.7
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
107
1248
0.85
0.90
2.3
2.2
ug/g
265.5
152.5
1.90
90
975
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
31
228
1.37
0.88
1.5
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
169
0.59
0.88
1.4
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
129
0.54
0.88
1.1
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
51
637
0.80
0.86
2.7
1.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
27
368
0.73
0.86
1.6
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
170
1908
0.88
0.86
12.4
8.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
224
2026
1.12
0.85
1.9
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
21
145
1.45
0.85
1.5
1.3
nmol/l
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
57
1.76
0.83
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
166
0.60
0.83
1.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
19
129
1.48
0.83
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
111
0.54
0.83
1.0
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
59
481
1.23
0.81
5.0
3.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
51
629
0.81
0.79
1.2
1.3
u/ml
136.6
227.7
0.80
45
576
(40758292) HTLV I+II Ab panel - Serum
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
0.3
—
0
5
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
42
529
0.79
0.78
1.2
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
175
0.63
0.78
1.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
99
0.50
0.77
2.8
17.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
39
305
1.28
0.76
1.3
1.3
mmol/l
54.4
62.6
0.91
31
248
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
27
200
1.35
0.76
1.3
1.4
u/ml
101.8
135.2
—
7
34
(3020874) Milk IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.1
—
2.6
—
0
10
(4146454)
12
185
0.65
0.75
3.5
2.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
24
2.09
0.74
2.0
1.1
—
—
—
0
0
(4034850)
36
458
0.78
0.74
14.1
12.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
135
0.59
0.73
1.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
26
1.93
0.70
1.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
41
1.71
0.70
1.0
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
48
391
1.23
0.69
2.4
4.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
9
146
0.61
0.69
1.3
1.4
u/l
12.3
14.0
—
9
135
(3020876) Protein [Mass/time] in 24 hour Urine
9
146
0.61
0.69
1.2
2.0
—
1.3
—
0
5
(3051611) Lipemic interference index of Serum or Plasma
22
161
1.37
0.68
6.5
3.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
37
293
1.27
0.68
1.4
2.0
mmol/l
1.9
1.7
0.49
37
285
(3004716) Salmonella sp identified in Stool by Organism specific culture
60
502
1.20
0.68
1.3
1.3
—
—
—
0
0
(4010399)
88
1012
0.86
0.67
1.4
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
17
119
1.43
0.67
1.9
1.7
%
8.9
11.0
1.12
17
119
(3037467) Urinalysis macro (dipstick) panel - Urine
962
9908
0.94
0.65
4.6
4.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
45
368
1.23
0.64
1.4
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
14
95
1.48
0.64
2.4
3.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
127
0.63
0.64
1.1
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
11
165
0.66
0.63
1.1
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
49
1.64
0.62
1.8
2.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
341
3203
1.08
0.62
4.0
4.1
ng/l
396.7
411.7
0.02
282
2758
(3023420) DNA double strand Ab [Units/volume] in Serum
6
105
0.57
0.61
1.0
1.4
—
33.6
—
0
7
(3019832) Treponema pallidum Ab [Presence] in Serum
33
412
0.80
0.61
1.6
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
20
0.00
0.60
0.0
1.3
—
27.7
—
0
12
(3022621) pH of Urine by Test strip
91
1034
0.87
0.60
3.1
3.2
—
—
—
0
0
(4212803)
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
21
0.00
0.60
0.0
1.3
—
6.8
—
0
13
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
53
1.51
0.58
1.6
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
8
53
1.51
0.58
1.6
2.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
631
6066
1.06
0.57
14.9
10.3
e9/l
0.0
0.0
0.49
513
4943
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
21
275
0.76
0.57
1.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
123
0.65
0.54
1.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
71
813
0.87
0.54
2.6
2.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
46
386
1.20
0.53
1.3
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
53
620
0.85
0.53
1.3
3.3
mg/l
32.3
75.7
1.29
41
503
(3006270) Folate [Moles/volume] in Blood
19
143
1.33
0.52
1.1
1.2
nmol/l
331.1
333.2
0.02
19
115
(3034860) Kappa light chains.free [Mass/volume] in Serum
53
619
0.85
0.52
1.3
3.3
mg/l
46.2
64.4
0.80
41
499
(3003434) Protein [Mass/volume] in Pleural fluid
36
296
1.22
0.51
1.4
1.5
g/l
32.7
30.7
0.42
31
267
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
64
1.41
0.51
1.1
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
64
1.41
0.51
1.1
2.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
39
467
0.83
0.51
1.2
3.4
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
11
157
0.70
0.51
1.3
1.2
u/l
12.8
15.0
0.18
11
144
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
65
1.39
0.50
1.1
2.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
16
213
0.75
0.50
1.3
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
93
1037
0.89
0.49
1.4
1.4
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
7
108
0.65
0.48
1.1
1.4
—
269.2
—
0
13
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
49
570
0.86
0.47
1.4
1.8
u/l
39.5
38.8
0.08
44
484
(40768793) Breast Pathology biopsy report
18
233
0.77
0.47
1.1
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
48
1.46
0.46
1.0
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
28
227
1.24
0.46
1.3
1.4
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
16
120
1.34
0.46
1.0
1.0
u/ml
4.0
2.7
—
7
35
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
5
82
0.61
0.45
1.0
1.1
mg/l
582.6
284.9
—
5
72
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
5
83
0.60
0.45
1.2
1.1
mg/l
84.0
43.1
—
5
72
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
102
1124
0.90
0.44
2.5
3.8
kpa
5.1
5.2
0.42
95
1030
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
20
157
1.28
0.43
2.4
2.0
u/field
1.9
2.2
0.15
12
46
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
23
184
1.25
0.43
2.0
2.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
180
1678
1.08
0.43
1.7
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
78
1.41
0.43
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
11
78
1.41
0.43
1.1
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
393
0.84
0.43
1.5
1.6
iu/ml
0.0
14.9
0.58
11
91
(3027035) Albumin [Mass/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.1
—
865.2
—
0
6
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.5
—
0
7
(40768443) Skin Pathology biopsy report
53
604
0.87
0.41
1.4
1.2
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.6
—
8.5
—
0
12
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.3
—
0.6
—
0
11
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
88
1.37
0.40
1.7
1.5
u/l
4.2
8.4
—
6
45
(3035350) Ketones [Presence] in Urine by Test strip
666
6851
0.96
0.40
3.9
3.9
estimate
0.0
0.0
0.00
147
1298
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
97
1.34
0.39
5.5
3.7
—
—
—
0
0
(44806420)
10
71
1.41
0.39
2.2
2.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
97
1062
0.91
0.39
2.5
3.7
mmol/l
1.8
2.0
0.20
72
787
(40761535) Cells panel - Urine sediment
124
1342
0.92
0.39
3.2
3.5
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
11
148
0.74
0.38
1.0
1.2
—
92.8
—
0
7
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
114
0.70
0.37
2.8
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
17
134
1.27
0.37
2.1
2.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
45
393
1.15
0.36
1.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
45
393
1.15
0.36
1.6
1.4
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
9
70
1.29
0.36
1.8
1.4
%
0.8
1.8
—
9
60
(3005719) IgG [Mass/volume] in Serum or Plasma
109
1004
1.09
0.36
2.5
2.7
g/l
10.0
10.8
1.11
103
908
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
130
1208
1.08
0.36
4.1
3.8
ng/l
95.4
97.1
0.07
114
1019
(3009343) pH of Capillary blood
102
1107
0.92
0.35
2.5
3.8
ph
7.4
7.4
—
8
136
(3019150) Specific gravity of Urine by Refractometry
294
3073
0.95
0.35
4.0
4.3
kg/l
1.0
1.0
0.14
42
481
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
126
1354
0.93
0.35
1.2
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
22
181
1.22
0.34
1.3
1.6
g/l
0.7
0.9
0.48
16
137
(3027008) Opiates [Presence] in Urine
17
136
1.25
0.33
2.1
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
17
136
1.25
0.33
2.2
2.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
36
312
1.16
0.33
1.6
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
76
692
1.10
0.33
1.2
2.4
g/l
3.6
3.9
1.58
51
490
(3032057) Clostridioides difficile [Presence] in Stool
6
46
1.31
0.33
1.8
1.8
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
87
0.69
0.33
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
87
0.69
0.33
1.5
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
87
0.69
0.33
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
87
0.69
0.33
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
90
0.67
0.32
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
90
0.67
0.32
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
90
0.67
0.32
1.0
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
76
693
1.10
0.32
1.2
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
76
694
1.10
0.32
1.2
2.4
g/l
7.7
7.5
0.69
53
506
(3037756) Immunofixation for Serum or Plasma
36
411
0.87
0.31
1.4
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
677
6921
0.97
0.29
3.8
4.0
estimate
0.0
0.0
0.50
145
1261
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
106
0.75
0.29
1.3
1.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
8
110
0.73
0.29
1.0
1.1
—
89.0
—
0
5
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
70
641
1.10
0.29
1.2
2.5
g/l
3.4
3.2
0.77
51
498
(3029937) Albumin [Presence] in Urine by Test strip
394
3818
1.04
0.28
4.0
4.2
estimate
0.0
0.0
0.69
131
1218
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
140
0.78
0.28
1.3
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
37
328
1.13
0.27
1.4
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
19
159
1.20
0.26
1.2
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
18
150
1.20
0.26
1.2
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
75
0.67
0.25
2.2
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
75
0.67
0.25
1.0
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
669
6825
0.97
0.25
5.1
5.3
estimate
0.0
0.0
0.50
147
1298
(3011397) Hemoglobin [Presence] in Urine by Test strip
318
3284
0.96
0.24
3.5
3.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
148
0.81
0.24
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
96
1.25
0.24
1.4
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
126
0.79
0.24
1.1
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
38
1.32
0.23
1.8
1.1
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
5
38
1.32
0.23
1.0
1.0
%
97.8
98.7
—
5
29
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
27
237
1.14
0.23
1.1
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
69
640
1.08
0.23
3.6
3.2
pmol/l
4.2
4.4
0.54
63
548
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
38
342
1.11
0.23
1.1
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
16
134
1.20
0.23
2.2
1.7
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
24
209
1.15
0.23
13.6
7.1
mmol/l
7.0
7.7
0.40
19
180
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
38
421
0.90
0.22
2.4
2.4
ug/min
131.0
98.3
0.23
23
254
(40767503) Oxygen content in Capillary blood by calculation
41
371
1.11
0.22
1.7
2.6
%
14.1
15.9
0.94
13
179
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
88
1.25
0.22
1.3
2.1
—
—
—
0
0
(4094501)
32
358
0.89
0.22
1.2
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
93
0.75
0.22
2.3
2.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
257
1.13
0.22
1.1
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
169
1619
1.05
0.22
2.6
3.0
ng/l
298.4
267.2
0.21
156
1483
(36660697) Celiac disease serology panel - Serum
78
833
0.93
0.21
1.2
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
516
5270
0.97
0.21
4.1
4.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
11
0.00
0.21
0.0
14.2
—
—
—
0
0
(3024316) Viscosity of Plasma
0
11
0.00
0.21
0.0
1.4
—
1.4
—
0
5
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
4705.2
—
0
6
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
21
241
0.87
0.21
2.5
3.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
4.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
4.9
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
283
0.88
0.21
1.4
1.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
22.0
—
0
13
(3015235) Bicarbonate [Moles/volume] in Capillary blood
43
470
0.91
0.20
3.3
3.4
mmol/l
23.3
25.1
1.77
38
405
(21494890) Protein electrophoresis panel - 24 hour Urine
16
187
0.85
0.20
1.1
2.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
18
155
1.16
0.20
1.1
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
67
626
1.07
0.19
2.3
2.1
ug/l
274.6
560.5
1.39
62
587
(3016879) Cocaine [Presence] in Urine
15
127
1.18
0.19
2.2
2.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
52
481
1.08
0.19
4.3
4.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
32
354
0.90
0.19
3.0
2.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
56
602
0.93
0.19
1.1
1.2
iu/ml
85.0
141.3
1.01
16
216
(3000330) Specific gravity of Urine by Test strip
81
858
0.94
0.18
5.1
3.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
119
1.18
0.17
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
119
1.18
0.17
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
167
1611
1.04
0.17
2.5
2.5
ug/l
5.0
7.1
1.43
131
1377
(3027456) Digoxin [Moles/volume] in Serum or Plasma
42
454
0.92
0.17
3.2
3.1
nmol/l
1.1
0.8
1.71
30
349
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
193
0.88
0.15
1.8
1.3
—
—
—
0
0
(4211845)
6
76
0.79
0.15
3.3
3.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
33
358
0.92
0.14
1.3
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
198
1.11
0.14
1.2
1.2
u/ml
347.3
291.2
0.29
15
113
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
84
1.19
0.14
1.1
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
84
1.19
0.14
1.1
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
84
1.19
0.14
1.1
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
84
1.19
0.14
1.1
1.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
106
0.85
0.13
1.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
27
248
1.09
0.12
1.4
1.7
iu/l
4.5
4.6
—
6
80
(3031040) Bacteria [#/volume] in Urine by Automated count
981
9732
1.02
0.12
4.9
4.9
e6/l
6344.9
2143.3
0.57
21
184
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
115
1111
1.04
0.12
2.0
1.7
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
12
137
0.88
0.12
1.7
2.3
ml
705.5
646.7
—
6
86
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
52
547
0.95
0.11
1.1
2.3
g/l
35.7
37.0
0.69
46
460
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
66
632
1.05
0.11
3.0
2.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
56
587
0.95
0.10
2.1
2.9
g/l
1.2
0.3
0.45
22
231
(4062490)
13
115
1.13
0.10
1.3
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
156
0.90
0.10
1.2
1.2
u/ml
2.6
5.2
—
9
65
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
638
6321
1.01
0.09
4.0
4.1
ng/l
48.6
64.3
0.40
524
4848
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
27
252
1.07
0.09
1.3
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
48
1.04
0.09
1.2
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
184
1.09
0.09
1.2
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
11
97
1.13
0.09
1.7
2.2
min
507.7
494.9
—
6
68
(4015189)
6
54
1.11
0.09
2.0
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
82
794
1.03
0.08
1.7
1.8
g/l
1.3
1.5
0.41
77
717
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
57
1.05
0.08
1.7
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
107
1.12
0.08
2.3
2.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
10
113
0.88
0.08
1.1
1.2
%
88.0
97.1
—
10
107
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
63
0.79
0.08
1.2
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
29
273
1.06
0.08
1.0
1.1
u/ml
2.7
13.9
—
7
19
(3048929) Epstein Barr virus Ab [Presence] in Serum
29
273
1.06
0.08
1.2
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
65
0.77
0.08
1.2
1.1
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
7
64
1.09
0.08
1.7
1.3
%
17.0
24.5
—
7
58
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
98
1.12
0.07
1.2
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
7
83
0.84
0.07
1.1
1.1
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
9
85
1.06
0.07
1.8
1.4
%
64.2
65.5
—
9
66
(3047189) Immunofixation for 24 hour Urine
8
92
0.87
0.06
1.1
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
33
346
0.95
0.06
2.5
3.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
24
226
1.06
0.06
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
242
2389
1.01
0.06
1.2
1.2
u/ml
2.0
1.6
0.20
67
610
(3035320) C reactive protein [Mass/volume] in Body fluid
9
103
0.87
0.06
2.3
2.4
—
—
—
0
0
(4024509)
16
148
1.08
0.06
1.8
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
47
454
1.04
0.06
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
19
202
0.94
0.05
3.8
3.8
—
—
—
0
0
(4306422)
16
149
1.07
0.05
1.1
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
60
584
1.03
0.05
1.1
2.6
g/l
0.4
1.4
3.08
53
494
(3003327) Ova and parasites identified in Stool by Light microscopy
36
347
1.04
0.04
1.6
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
124
1259
0.98
0.04
1.3
2.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
91
1.10
0.04
1.4
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
115
1167
0.98
0.04
4.6
3.0
ml/min/173m2
60.4
61.1
0.07
43
504
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
653
0.98
0.03
1.1
2.5
g/l
9.5
10.6
1.50
56
545
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
15
159
0.94
0.03
1.2
1.2
u/ml
1.5
4.1
—
6
45
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
128
1265
1.01
0.03
1.6
1.8
%
1.6
1.6
0.29
108
1053
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
22
211
1.04
0.03
1.2
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
21
219
0.96
0.03
3.0
2.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
80
811
0.99
0.02
2.5
3.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
18
188
0.96
0.02
1.6
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
255
2538
1.01
0.01
21.7
29.4
inr
1.2
1.5
3.65
47
342
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
137
0.95
0.01
1.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
106
0.94
0.01
2.2
2.3
—
—
—
0
0
(44790047)
16
166
0.96
0.00
1.4
1.5
—
—
—
0
0
(44790049)
16
166
0.96
0.00
1.4
1.5
—
—
—
0
0
(44790048)
16
166
0.96
0.00
1.4
1.5
—
—
—
0
0
(44806118)
16
166
0.96
0.00
1.4
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
361
3616
1.00
0.00
3.8
3.7
—
—
—
0
0
(3013512) EKG study
467
4676
1.00
0.00
4.1
4.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
14
145
0.97
0.00
1.0
1.1
—
14.8
—
0
7
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
25
245
1.02
0.00
1.3
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
141
0.99
0.00
1.2
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
141
0.99
0.00
1.2
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
141
0.99
0.00
1.2
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
104
0.96
0.00
1.1
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
15
146
1.03
0.00
1.1
1.1
%
119.9
114.4
0.29
15
133
(3007164) IgA [Mass/volume] in Serum or Plasma
217
2174
1.00
0.00
1.5
1.5
g/l
2.6
2.8
0.41
134
1272
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
152
0.99
0.00
1.1
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
12
118
1.02
0.00
1.0
1.5
—
23.6
—
0
22
(3026389) Candida sp identified in Specimen by Organism specific culture
15
152
0.99
0.00
1.9
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
23
228
1.01
0.00
1.7
2.3
mg/l
48.2
22.8
—
5
50
(4268621)
11
108
1.02
0.00
2.3
2.3
—
—
—
0
0
(3035880) pH of Pleural fluid
12
117
1.03
0.00
1.2
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
36
363
0.99
0.00
1.9
2.2
g/l
117.3
128.9
1.30
23
267
(3051387) C reactive protein [Mass/volume] in Capillary blood
38
377
1.01
0.00
3.5
3.6
mg/l
43.0
29.2
1.02
28
251
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
1745.2
—
0
5
(3011325) HIV 1+2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
69
0.87
0.00
3.3
3.4
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
5
54
0.93
0.00
1.2
1.3
g/l
—
0.1
—
0
6
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000012) Reticulocyte production index
8
87
0.92
0.00
1.4
1.6
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
83
0.96
0.00
1.0
1.3
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
83
0.96
0.00
1.0
1.3
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
10.2
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
2.4
—
0
7
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
7.8
—
0
5
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
12
120
1.00
0.00
2.9
3.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
4.5
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
211.2
—
0
5
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
6
65
0.92
0.00
2.2
1.6
nmol/l
13.5
15.9
—
6
55
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_STOMACH – Malignant neoplasm of stomach
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).